414 related articles for article (PubMed ID: 18227598)
21. Increase in minimum inhibitory concentration to quinolones and ceftriaxone in salmonellae causing enteric fever.
Sekar U; Srikanth P; Kindo AJ; Babu VP; Ramasubramanian V
J Commun Dis; 2003 Sep; 35(3):162-9. PubMed ID: 15796408
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility to azithromycin among Salmonella enterica Typhi and Paratyphi A isolates from India.
Misra R; Prasad KN
J Med Microbiol; 2016 Dec; 65(12):1536-1539. PubMed ID: 27902389
[TBL] [Abstract][Full Text] [Related]
23. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
Gupta V; Kaur J; Kaistha N
Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance.
Hooda Y; Sajib MSI; Rahman H; Luby SP; Bondy-Denomy J; Santosham M; Andrews JR; Saha SK; Saha S
PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007868. PubMed ID: 31730615
[TBL] [Abstract][Full Text] [Related]
25. A three-year review of antimicrobial resistance of Salmonella enterica serovars Typhi and Paratyphi A in Pakistan.
Qamar FN; Azmatullah A; Kazi AM; Khan E; Zaidi AK
J Infect Dev Ctries; 2014 Aug; 8(8):981-6. PubMed ID: 25116662
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of azithromycin, newer quinolones and cephalosporins in ciprofloxacin-resistant Salmonella causing enteric fever.
Capoor MR; Rawat D; Nair D; Hasan AS; Deb M; Aggarwal P; Pillai P
J Med Microbiol; 2007 Nov; 56(Pt 11):1490-1494. PubMed ID: 17965350
[TBL] [Abstract][Full Text] [Related]
27. Decreased ciprofloxacin susceptibility in Salmonella Typhi and Paratyphi infections in ill-returned travellers: the impact on clinical outcome and future treatment options.
Hassing RJ; Goessens WH; Mevius DJ; van Pelt W; Mouton JW; Verbon A; van Genderen PJ
Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1295-301. PubMed ID: 23609512
[TBL] [Abstract][Full Text] [Related]
28. Renaissance of Conventional First-Line Antibiotics in
Khanal PR; Satyal D; Bhetwal A; Maharjan A; Shakya S; Tandukar S; Parajuli NP
Biomed Res Int; 2017; 2017():2868143. PubMed ID: 29018810
[TBL] [Abstract][Full Text] [Related]
29. Typhoidal Salmonella strains in Pakistan: an impending threat of extensively drug-resistant Salmonella Typhi.
Hussain A; Satti L; Hanif F; Zehra NM; Nadeem S; Bangash TM; Peter A
Eur J Clin Microbiol Infect Dis; 2019 Nov; 38(11):2145-2149. PubMed ID: 31377955
[TBL] [Abstract][Full Text] [Related]
30. Development of a real-time PCR assay for detection of gyrA mutations associated with reduced susceptibility to ciprofloxacin in Salmonella enterica serovar typhi and paratyphi A.
Morita M; Ito K; Hirose K; Takahashi H; Shimuta K; Terajima J; Ohnishi M; Harada M; Matsuzaki M; Watanabe H; Izumiya H
Microbiol Immunol; 2006; 50(9):707-11. PubMed ID: 16985292
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial susceptibility patterns of Salmonella typhi and Salmonella paratyphi A in a tertiary care hospital.
Raza S; Tamrakar R; Bhatt CP; Joshi SK
J Nepal Health Res Counc; 2012 Sep; 10(22):214-7. PubMed ID: 23281454
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial resistance and molecular subtypes of
Kong XX; Dong C; Ji H; Wang Y; Bao CC; Huo X; Qian HM
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Nov; 38(11):1546-1550. PubMed ID: 29141347
[No Abstract] [Full Text] [Related]
33. Re-emergence of susceptibility to conventional first line drugs in Salmonella isolates from enteric fever patients in Nepal.
Chand HJ; Rijal KR; Neupane B; Sharma VK; Jha B
J Infect Dev Ctries; 2014 Nov; 8(11):1483-7. PubMed ID: 25390062
[TBL] [Abstract][Full Text] [Related]
34. An increase in enteric fever cases due to Salmonella Paratyphi A in & around Chandigarh.
Gupta V; Kaur J; Chander J
Indian J Med Res; 2009 Jan; 129(1):95-8. PubMed ID: 19287065
[TBL] [Abstract][Full Text] [Related]
35. A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital.
Zellweger RM; Basnyat B; Shrestha P; Prajapati KG; Dongol S; Sharma PK; Koirala S; Darton TC; Dolecek C; Thompson CN; Thwaites GE; Baker SG; Karkey A
PLoS Negl Trop Dis; 2017 Nov; 11(11):e0006051. PubMed ID: 29176850
[TBL] [Abstract][Full Text] [Related]
36. Alternatives to ciprofloxacin use for enteric Fever, United kingdom.
Threlfall EJ; de Pinna E; Day M; Lawrence J; Jones J
Emerg Infect Dis; 2008 May; 14(5):860-1. PubMed ID: 18439388
[TBL] [Abstract][Full Text] [Related]
37. Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Bhattacharya SS; Das U; Choudhury BK
Indian J Med Res; 2011 Apr; 133(4):431-3. PubMed ID: 21537098
[TBL] [Abstract][Full Text] [Related]
38. Changing Patterns in Enteric Fever Incidence and Increasing Antibiotic Resistance of Enteric Fever Isolates in the United States, 2008-2012.
Date KA; Newton AE; Medalla F; Blackstock A; Richardson L; McCullough A; Mintz ED; Mahon BE
Clin Infect Dis; 2016 Aug; 63(3):322-9. PubMed ID: 27090993
[TBL] [Abstract][Full Text] [Related]
39. First isolation of ciprofloxacin-resistant Salmonella enterica serovar Typhi in Taiwan.
Lee CJ; Su LH; Huang YC; Chiu CH
J Microbiol Immunol Infect; 2013 Dec; 46(6):469-73. PubMed ID: 23465712
[TBL] [Abstract][Full Text] [Related]
40. A need to revise ciprofloxacin breakpoints for Salmonella in human beings.
Gupta V; Kaur J
Int J Infect Dis; 2008 Nov; 12(6):e143-4. PubMed ID: 18514007
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
